Omasept (Omeprazole)

Omeprazole, the active ingredient in Omasept, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Omasept as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omasept is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Omasept may cause a range of adverse reactions. Most are mild and transient.

Common Side Effects: - Headache: mild headache reported in clinical studies. - Diarrhea: loose stools occurring during treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Acute interstitial nephritis: inflammation of kidney interstitium. - Severe allergic reaction: rash, itching, swelling, or breathing difficulty. - Low magnesium levels: hypomagnesemia with long‑term use. - Fracture risk: increased risk of hip, wrist or spine fractures with prolonged therapy.

When using Omasept, consider the following safety measures: - Assess renal function: adjust use in patients with severe kidney impairment. - Evaluate hepatic function: use cautiously in moderate to severe liver disease. - Monitor long‑term use: periodic assessment for bone health and magnesium levels. - Pregnancy and lactation: weigh benefits against potential risks; consult a healthcare professional. - Drug‑interaction review: check for medicines that may affect acid suppression. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omasept can interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect due to decreased activation. - Atazanavir: markedly reduced absorption of the antiviral. - Dasatinib: lowered plasma concentrations affecting efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR INR "). - Phenytoin: possible "). - Ketoconazole: enhanced absorption of the antifungal. - Rifampicin: decreased plasma levels of omeprazole. - Staphyl .